Search for a trial

A Multi-Center, Prospective, Randomized, Double-Blind,
Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of AMR101
on Cardiovascular Health and Mortality in Hypertriglyceridemic Patients
with Cardiovascular Disease or at High Risk for Cardiovascular Disease:
REDUCE-IT (Reduction of Cardiovascular Events with EPA * Intervention Trial)

The primary objective is, in patients at low-density lipoprotein cholesterol (LDL-C) goal while on statin therapy, with established cardiovascular disease (CVD) or at high risk for CVD, and hypertriglyceridemia (fasting triglycerides [TG] *200 mg/dL…